CABIT: a novel biomarkers-integrated inflammatory risk tool for ischemic heart disease developed in the USA and prospectively validated in China.

ABSTRACT:

SUBMITTER: Hu W 

PROVIDER: S-EPMC12910730 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature